Original work 2022:'Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial' (Knops)2022: 'Should variants of unknown significance (VUS) be disclosed to patients in cardiogenetics or not; only in case of high suspicion of pathogenicity?' (Van der Crabben)